| scholarly article | Q13442814 |
| P2093 | author name string | Burks TF | |
| Hruby VJ | |||
| Kramer TH | |||
| Kazmierski W | |||
| Shook JE | |||
| Ayres EA | |||
| Wire WS | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| pharmacology | Q128406 | ||
| P304 | page(s) | 544-551 | |
| P577 | publication date | 1989-05-01 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo | |
| P478 | volume | 249 |
| Q44335927 | A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat. |
| Q34603199 | Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae |
| Q35510067 | Activation of μ opioid receptors modulates inflammation in acute experimental colitis. |
| Q37317909 | Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of m |
| Q30417531 | Central effects of ethanol interact with endogenous mu-opioid activity to control isolation-induced analgesia in maternally separated infant rats |
| Q37219300 | Centralization of noxious stimulus-induced analgesia (NSIA) is related to activity at inhibitory synapses in the spinal cord |
| Q35048680 | Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum |
| Q36015414 | Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists |
| Q43263548 | Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex |
| Q36155156 | Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition |
| Q35096042 | Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists |
| Q33893723 | Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists |
| Q36869401 | Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore. |
| Q44350852 | Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. |
| Q41633616 | Estrogen facilitates and the kappa and mu opioid receptors mediate antinociception produced by intrathecal (-)-pentazocine in female rats |
| Q34606762 | Ethanol-induced social facilitation in adolescent rats: role of endogenous activity at mu opioid receptors |
| Q34124185 | In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function |
| Q36054309 | In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay |
| Q24302002 | Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence |
| Q44336630 | Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure |
| Q44349884 | Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord |
| Q33943736 | Methamphetamine-induced stereotypy correlates negatively with patch-enhanced prodynorphin and arc mRNA expression in the rat caudate putamen: the role of mu opioid receptor activation |
| Q34459367 | Mu opioid receptor activation normalizes temporo-ammonic pathway driven inhibition in hippocampal CA1 |
| Q55229974 | Negative modulation of spinal κ-opioid receptor-mediated antinociception by the µ-opioid receptor at selective doses of (-)-pentazocine. |
| Q35049029 | Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence |
| Q43264463 | Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine |
| Q36932895 | Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats |
| Q44336851 | Reflex peristalsis in the guinea pig isolated ileum is endogenously controlled by kappa opioid receptors |
| Q24548810 | Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors |
| Q60729558 | Synthesis, Biological, and Structural Explorations of New Zwitterionic Derivatives of 14-O-Methyloxymorphone, as Potent μ/δ Opioid Agonists and Peripherally Selective Antinociceptives |
| Q44334198 | The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone |
| Q51707265 | Voltage-clamp experiments reveal receptor type-dependent modulation of chloride secretion in the guinea pig colonic mucosa by intestinal opioids |
Search more.